FDA introduced a new "Plausible Mechanism Framework." Under this policy, certain gene therapies and RNA-based treatments ...

A research team led by Purdue University's W. Andy Tao has discovered a new type of protein modification related to cellular ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

Academics innovate gene therapy manufacturing to cut costs and improve access, addressing commercialization challenges and ...

Nadofaragene firadenovec-vncg is the only FDA-approved nonreplicating intravesical gene therapy for high-risk ...

The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.

The study of mutant p53 isoforms lies at the forefront of cancer biology, revealing the profound impact of TP53 gene alterations on tumor progression and ...

Vinay Prasad, M.D., is out again as the chief medical and scientific officer for the U.S. Food and Drug Administration (FDA).

Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...